Related references
Note: Only part of the references are listed.Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trial
Stephan A. Goerigk et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Time in treatment: Examining mental illness trajectories across inpatient psychiatric treatment
Hyuntaek Oh et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature
Karissa M. Johnston et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal et al.
NEURON (2019)
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
Gang Li et al.
ANNALS OF GENERAL PSYCHIATRY (2019)
Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study
Tyler S. Kaster et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD
Marijn Lijffijt et al.
FRONTIERS IN PSYCHIATRY (2019)
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Johan Reutfors et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
Carola Rong et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Association of Cumulative Childhood Adversity and Adolescent Violent Offending With Suicide in Early Adulthood
Emma Bjorkenstam et al.
JAMA PSYCHIATRY (2018)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
Steven J. Pennybaker et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Reevaluating the Efficacy and Predictability of Antidepressant Treatments A Symptom Clustering Approach
Adam M. Chekroud et al.
JAMA PSYCHIATRY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
L. Booij et al.
TRANSLATIONAL PSYCHIATRY (2016)
Serum Interleukin-6 Is a Predictive Biomarker for Ketamine's Antidepressant Effect in Treatment-Resistant Patients With Major Depression
Jian-Jun Yang et al.
BIOLOGICAL PSYCHIATRY (2015)
Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults
Stephen F. Smagula et al.
JAMA PSYCHIATRY (2015)
AMYGDALA RESPONSE TO NEGATIVE STIMULI PREDICTS PTSD SYMPTOM ONSET FOLLOWING A TERRORIST ATTACK
Katie A. McLaughlin et al.
DEPRESSION AND ANXIETY (2014)
The Intraoperative Administration of Ketamine to Burned US Service Members Does Not Increase the Incidence of Post-Traumatic Stress Disorder
Laura L. McGhee et al.
MILITARY MEDICINE (2014)
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial
Adriana Feder et al.
JAMA PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Childhood Maltreatment Predicts Unfavorable Course of Illness and Treatment Outcome in Depression: A Meta-Analysis
Valentina Nanni et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Trajectories of change in depression severity during treatment with antidepressants
R. Uher et al.
PSYCHOLOGICAL MEDICINE (2010)
Testing for Factorial Invariance in the Context of Construct Validation
Dimiter M. Dimitrov
MEASUREMENT AND EVALUATION IN COUNSELING AND DEVELOPMENT (2010)
Growth mixture modeling: A method for identifying differences in longitudinal change among unobserved groups
Nilam Ram et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT (2009)
Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study
Karen L. Nylund et al.
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL (2007)
Modeling sensitization to stimulants in humans -: An [11C] raclopride/positron emission tomography study in healthy men
Isabelle Boileau et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
Disruption of sensitization to methylphenidate by a single administration of MK-801
O Gaytan et al.
LIFE SCIENCES (2002)
Share Paper
